CLOV
Get informed when a big investor buys or sells
+ FollowOvervalued by 172.6% based on the discounted cash flow analysis.
| Market cap | $2.27 Billion |
|---|---|
| Enterprise Value | $2.07 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.17 |
| Beta | 2.48 |
| Outstanding Shares | 524,186,885 |
| P/E Ratio | -108.15 |
|---|---|
| PEG | 29.65 |
| Price to Sales | 1.1 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 0.84 |
| Enterprise Value to EBIT | -112.79 |
| Enterprise Value to Net Income | -113 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.3286▼ 25.00% |
|---|---|
| Total Calls | 10,304,600▲ 138.15% |
| Total Puts | 3,386,400▲ 35.25% |
Holdings and activity of institutional investors.
| Ownership % | 28.98%▲ 4.33% |
|---|---|
| Total Invested | $791.46M▲ 252.38% |
| Investors Holding | 242▲ 22.00% |
No data
Clover Health is a healthcare technology company with a deeply rooted mission of improving every life. Clover uses its proprietary technology platform to collect, structure, and analyze health and behavioral data to improve medical outco...